Editorial: Impact of genome instability on human health

Editorial: Impact of genome instability on human health

Bibliographic Details
Main Authors:	Swagat Ray, Sanjiban Chakrabarty, Arnab Ray Chaudhuri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Molecular Biosciences
Subjects:	DNA damage PARP inhibition (PARPi) genomic instability cancer transcription factor
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1243968/full

Similar Items

Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance
by: Taylor Lovsund, et al.
Published: (2023-07-01)

TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors
by: Roisin M. McAvera, et al.
Published: (2024-04-01)

Editorial: Genomic Instability and Neurodegeneration
by: Julia Fuchs, et al.
Published: (2022-06-01)

Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives
by: Kai Zimmer, et al.
Published: (2021-10-01)

Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs
by: Maria Giulia Nizi, et al.
Published: (2023-08-01)

Editorial: Exploring genomic instability of cancers: applications in diagnosis and treatment
by: Dong Zhang, et al.
Published: (2025-02-01)

Genomic instability and cancer: lessons from Drosophila
by: Stephan U. Gerlach, et al.
Published: (2020-06-01)

Editorial: Chromosomal fragile sites, genome instability and human diseases
by: Qing Hu, et al.
Published: (2023-01-01)

New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
by: Ye Han, et al.
Published: (2020-11-01)

Harnessing DNA Double-Strand Break Repair for Cancer Treatment
by: Anika Trenner, et al.
Published: (2019-12-01)

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma
by: Ahmed Bilal Khalid, et al.
Published: (2024-11-01)

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
by: Andrei Kachmazov, et al.
Published: (2022-09-01)

PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer
by: Chaohua Liu, et al.
Published: (2024-05-01)

Editorial: Current understanding of genomic and chromosomal instabilities in solid malignancies
by: Pavel Vodicka, et al.
Published: (2023-08-01)

Tumor Hypoxia Drives Genomic Instability
by: Ming Tang, et al.
Published: (2021-03-01)

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
by: Alexander Giesen, et al.
Published: (2023-09-01)

Transcription shapes DNA replication initiation to preserve genome integrity
by: Yang Liu, et al.
Published: (2021-06-01)

Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage
by: Caroline Townsend Stork, et al.
Published: (2016-08-01)

Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
by: Yu-Yi Chu, et al.
Published: (2022-10-01)

PROBING GENOME MAINTENANCE FUNCTIONS OF HUMAN RECQ1
by: Furqan Sami, et al.
Published: (2013-03-01)

Regulators of Homologous Recombination Repair as Novel Targets for Cancer Treatment
by: Małgorzata ekrajewska, et al.
Published: (2015-03-01)

Transcription–Replication Coordination
by: Marco Saponaro
Published: (2022-01-01)

MiR-4521 perturbs FOXM1-mediated DNA damage response in breast cancer
by: Raviprasad Kuthethur, et al.
Published: (2023-03-01)

Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics
by: Iain A. Richard, et al.
Published: (2022-01-01)

Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer
by: Rafael Grochot, et al.
Published: (2023-06-01)

Idiopathic Infertility as a Feature of Genome Instability
by: Agrita Puzuka, et al.
Published: (2021-06-01)

Characterization of the human <i>IDH1</i> gene promoter
by: Yutaka Takihara, et al.
Published: (2023-08-01)

PARP1 Upregulation in Recurrent Oral Cancer and Treatment Resistance
by: Feifei Wang, et al.
Published: (2022-01-01)

Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer
by: Qianying Zhao, et al.
Published: (2024-07-01)

Replication Stress and Consequential Instability of the Genome and Epigenome
by: Pawlos S. Tsegay, et al.
Published: (2019-10-01)

Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma
by: Alexander Quaas, et al.
Published: (2019-02-01)

PARP inhibitors in cancer therapy: Magic bullets but moving targets
by: Girish M. Shah, et al.
Published: (2013-11-01)

Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity
by: Nicholas Sciascia, et al.
Published: (2020-02-01)

Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
by: Irene Paterniti, et al.
Published: (2021-07-01)

Cleavage-defective Topoisomerase I mutants sharply increase G-quadruplex-associated genomic instability
by: Alexandra Berroyer, et al.
Published: (2022-01-01)

Sustained complete response to cytotoxic therapy and the PARP inhibitor veliparib in metastatic castration resistant prostate cancer – a case report
by: David J VanderWeele, et al.
Published: (2015-07-01)

The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma
by: Jerred P. Pletcher, et al.
Published: (2021-07-01)

The G2 checkpoint activated by DNA damage does not prevent genome instability in plant cells
by: JESÚS A CARBALLO, et al.
Published: (2006-01-01)

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy
by: Honoka Obata, et al.
Published: (2023-07-01)

Understanding the Human RECQ5 Helicase—Connecting the Dots from DNA to Clinics
by: Chiefe Mo, et al.
Published: (2023-08-01)